Skip to main content
SpringerLink
Log in

The Australian Therapeutic Goods Administration (TGA) is reviewing the safety of sibutramine

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Sibutramine. Australian Prescriber 33: 81, No. 2, Apr 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Australian Therapeutic Goods Administration (TGA) is reviewing the safety of sibutramine. React. Wkly. 1304, 5 (2010). https://doi.org/10.2165/00128415-201013040-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013040-00014

Keywords

Search

Navigation